Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer.
10.3346/jkms.2015.30.6.749
- Author:
Chang Seok BANG
1
;
Gwang Ho BAIK
;
In Soo SHIN
;
Jin Bong KIM
;
Ki Tae SUK
;
Jai Hoon YOON
;
Yeon Soo KIM
;
Dong Joon KIM
Author Information
1. Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea. baikgh@hallym.or.kr
- Publication Type:Original Article ; Meta-Analysis ; Review
- Keywords:
Stomach Neoplasms;
Helicobacter pylori;
Metachronous Neoplasms
- MeSH:
Adult;
Aged;
Aged, 80 and over;
Combined Modality Therapy/statistics & numerical data;
Comorbidity;
Female;
Gastroscopy/*statistics & numerical data;
Helicobacter Infections/epidemiology/*prevention & control;
Humans;
Incidence;
Male;
Middle Aged;
Neoplasms, Second Primary/*epidemiology/pathology/*prevention & control;
Risk Factors;
Stomach Neoplasms/*epidemiology/pathology/*surgery;
Treatment Outcome
- From:Journal of Korean Medical Science
2015;30(6):749-756
- CountryRepublic of Korea
- Language:English
-
Abstract:
Controversies persist regarding the effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer (EGC). The aim of this study was to assess the efficacy of Helicobacter pylori eradication after endoscopic resection of EGC for the prevention of metachronous gastric cancer. A systematic literature review and meta-analysis were conducted using the core databases PubMed, EMBASE, and the Cochrane Library. The rates of development of metachronous gastric cancer between the Helicobacter pylori eradication group vs. the non-eradication group were extracted and analyzed using risk ratios (RRs). A random effect model was applied. The methodological quality of the enrolled studies was assessed by the Risk of Bias table and by the Newcastle-Ottawa Scale. Publication bias was evaluated through the funnel plot with trim and fill method, Egger's test, and by the rank correlation test. Ten studies (2 randomized and 8 non-randomized/5,914 patients with EGC or dysplasia) were identified and analyzed. Overall, the Helicobacter pylori eradication group showed a RR of 0.467 (95% CI: 0.362-0.602, P < 0.001) for the development of metachronous gastric cancer after endoscopic resection of EGC. Subgroup analyses showed consistent results. Publication bias was not detected. Helicobacter pylori eradication after endoscopic resection of EGC reduces the occurrence of metachronous gastric cancer.
